6,528 Bottles of High Blood Pressure Medication Recalled by Glenmark Pharmaceuticals from US Market

Glenmark Pharmaceuticals is in the process of pulling back 6,528 bottles of medication used for high blood pressure treatment from the American market due to issues with dissolution specifications, PTI reported citing the US Food and Drug Administrat

Exports in Indian Pharma likely to Surge 15% in FY24

Exports in the India's pharmaceutical sector to the US have surged 15% in the first 11 months of the financial year 2024 despite being faced with many regulatory challenges and rise in product pricing pressures.

SaniSure Advances Drug Speed To Market with Fill4Sure Launch

SaniSure, a worldwide player in single-use bioprocessing items, has declared the launch of Fill4Sure, a custom single-use filling gathering intended to facilitate drugs to market and construct security, effectiveness and repeatability into your...

Bank of Maharashtra's MAHADOC Loan Scheme for Doctors: Empowering Medical Professionals, Building a Healthier Nation

A nation's healthcare system is only as strong as its infrastructure. From well-equipped hospitals to specialized clinics, a robust network of facilities is essential for delivering quality healthcare to every citizen.

India's Pharmaceutical Exports To USA Increase 15% in 11 months of FY24

India's pharmaceutical exports to the USA increased by 15% in the first 11 months of the last monetary year despite administrative difficulties and rising estimating pressures. The speed of exports has dramatically increased from the 6.18%...

Harmony Biosciences Sign Pact with Bioprojet To Develop TPM 1116

Harmony Biosciences, a dedicated firm in creating and conveying medicines for uncommon neurological sicknesses, has declared a licensing contract with Bioprojet to create, make and popularize TPM-1116, an exceptionally strong and specific oral...

© 2024 India Pharma Outlook. All Rights Reserved.